サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1507326

注意欠陥多動性障害（ADHD）の世界市場規模調査：薬物タイプ別、人口統計別、流通チャネル別、地域別予測：2022-2032年

Global Attention Deficit Hyperactivity Disorder Market Size study, by Drug Type (Stimulants, Non-stimulants) by Demographics (Children, Adults) by Distribution Channel (Retail Pharmacy, Hospital Pharmacy) and Regional Forecasts 2022-2032

出版日
ページ情報
英文 200 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
注意欠陥多動性障害（ADHD）の世界市場規模調査：薬物タイプ別、人口統計別、流通チャネル別、地域別予測：2022-2032年
出版日: 2024年07月01日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文 200 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の注意欠陥多動性障害市場は、2023年に約143億米ドルと評価され、予測期間2024年から2032年にかけて3.70％以上の健全な成長率で成長すると予測されています。

注意欠陥多動性障害は、一般的に小児期に発症し、しばしば成人期まで継続する神経発達障害です。不注意、多動性、衝動性の持続的なパターンが特徴で、機能や発達を妨げます。また、新しく改良された薬剤が絶えず開発されています。長時間作用型の覚醒剤や非覚醒剤へのシフトが進んでおり、従来の治療に反応しにくい患者にも選択肢が広がっています。グアンファシンやアトモキセチンのような非刺激薬は、乱用のリスクが低く、患者によっては副作用のプロファイルも良好なため、人気が高まっています。したがって、この動向は世界の注意欠陥多動性障害市場の成長をサポートすると予想されます。

さらに、ADHDの認知度と認識が世界的に高まり、診断率の上昇につながっています。診断基準の改善やスクリーニングプロセスの改善により、ADHDと診断され治療を受けている人が増えています。また、ADHDの薬理学的治療と非薬理学的治療の両方において著しい進歩が見られます。有効性と安全性のプロファイルが改善された新薬や行動療法、デジタル治療薬が市場を拡大しています。さらに、ADHDやその症状、生活の質への影響に関する一般市民や専門家の意識の高まりが、より多くの人々に診断や治療を求めるよう促しています。ヘルスケア組織や患者団体による教育キャンペーンや支持がこの点で役立っており、市場の成長を支えていると予想されます。しかし、厳格な管理・運営手続き、薬価の高騰、非刺激性ADHD治療薬の限られた入手可能性などが、2024-2032年の予測期間中、世界の注意欠陥多動性障害市場の成長を最も阻害すると予想される要因です。

注意欠陥多動性障害の世界市場調査において考慮した主要地域は、アジア太平洋地域、北米、欧州、ラテンアメリカ、その他世界のその他の地域です。2023年、北米は収益の面で最大の地域市場でした。北米の注意欠陥多動性障害市場は、様々な薬物のイントロダクションと急速な採用により拡大しています。さらに、好意的な償還政策、現在の治療法に対する認知度の向上、患者の負担軽減の改善、新製品の導入などが、予測期間を通じて市場の拡大を促進すると予想されます。2023年9月、Tris Pharma, Inc.は、カナダ保健省が6～12歳の小児のADHD治療薬としてキリバントER（徐放性）の使用を承認したと発表しました。キリバントERは、経口懸濁液とチュアブル錠の2つの剤形があり、カナダで初めて1日1回投与の長時間作用型メチルフェニデートのチュアブル錠と経口懸濁液がADHD治療薬として承認されました。一方、アジア太平洋地域は予測期間中に最も高いCAGRで成長すると予想されています。

目次

第1章 世界の注意欠陥多動性障害市場の定義と調査前提条件

  • 調査目的
  • 市場の定義
  • 調査前提条件
    • 包含と除外
    • 制限事項
    • 供給サイドの分析
      • 入手可能性
      • インフラ
      • 規制環境
      • 市場競争
      • 経済性（消費者の視点）
    • 需要サイド分析
      • 規制の枠組み
      • 技術の進歩
      • 環境への配慮
      • 消費者の意識と受容
  • 調査手法
  • 調査対象年
  • 通貨換算レート

第2章 エグゼクティブサマリー

  • 注意欠陥多動性障害の世界市場規模＆予測（2022年～2032年）
  • 地域別概要
  • セグメント別概要
    • 薬物タイプ別
    • 人口統計別
    • 流通チャネル別
  • 主要動向
  • 景気後退の影響
  • アナリストの結論・提言

第3章 注意欠陥多動性障害の世界市場力学

  • 市場促進要因
  • 市場の課題
  • 市場機会

第4章 注意欠陥多動性障害の世界市場産業分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
    • ポーターのファイブフォースモデルへの未来的アプローチ
    • ポーターのファイブフォースの影響分析
  • PESTEL分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 注意欠陥多動性障害の世界市場規模・予測：薬剤タイプ別 2022年～2032年

  • 刺激薬
  • 非刺激剤

第6章 注意欠陥多動性障害の世界市場規模・予測：人口統計別 2022年～2032年

  • 小児
  • 成人

第7章 注意欠陥多動性障害の世界市場規模・予測：流通チャネル別 2022-2032年

  • 小売薬局
  • 病院薬局

第8章 注意欠陥多動性障害の世界市場規模・予測：地域別 2022-2032年

  • 北米の注意欠陥多動性障害市場
    • 米国
      • 薬剤タイプ別、市場規模＆予測、2022-2032年
      • 人口統計別、市場規模＆予測、2022-2032年
      • 流通チャネル別、市場規模＆予測、2022-2032年
    • カナダの注意欠陥多動性障害市場
  • 欧州の注意欠陥多動性障害市場
    • 英国の注意欠陥多動性障害市場
    • ドイツの注意欠陥多動性障害市場
    • フランスの注意欠陥多動性障害市場
    • スペインの注意欠陥多動性障害市場
    • イタリアの注意欠陥多動性障害市場
    • その他欧州の注意欠陥多動性障害市場
  • アジア太平洋の注意欠陥多動性障害市場
    • 中国の注意欠陥多動性障害市場
    • インドの注意欠陥多動性障害市場
    • 日本の注意欠陥多動性障害市場
    • オーストラリアの注意欠陥多動性障害市場
    • 韓国の注意欠陥多動性障害市場
    • その他アジア太平洋地域の注意欠陥多動性障害市場
  • ラテンアメリカの注意欠陥多動性障害市場
    • ブラジルの注意欠陥多動性障害市場
    • メキシコの注意欠陥多動性障害市場
    • その他ラテンアメリカの注意欠陥多動性障害市場
  • 中東・アフリカの注意欠陥多動性障害市場
    • サウジアラビアの注意欠陥多動性障害市場
    • 南アフリカの注意欠陥多動性障害市場
    • その他中東とアフリカの注意欠陥多動性障害市場

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Eli Lilly and Company
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 市場戦略
    • Pfizer Inc.
    • Johnson & Johnson Services Inc.
    • Lupin Limited
    • Novartis AG
    • Takeda Pharmaceutical Company Limited
    • Mallinckrodt Inc.
    • Purdue Pharma LP
    • NEOS Therapeutics Inc.
    • Supernus Pharmaceutical, Inc.

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
図表

LIST OF TABLES

  • TABLE 1. Global Attention Deficit Hyperactivity Disorder market, report scope
  • TABLE 2. Global Attention Deficit Hyperactivity Disorder market estimates & forecasts by Region 2022-2032 (USD Billion)
  • TABLE 3. Global Attention Deficit Hyperactivity Disorder market estimates & forecasts by Drug Type 2022-2032 (USD Billion)
  • TABLE 4. Global Attention Deficit Hyperactivity Disorder market estimates & forecasts by Demographics 2022-2032 (USD Billion)
  • TABLE 5. Global Attention Deficit Hyperactivity Disorder market estimates & forecasts by Distribution Channel 2022-2032 (USD Billion)
  • TABLE 6. Global Attention Deficit Hyperactivity Disorder market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 7. Global Attention Deficit Hyperactivity Disorder market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 8. Global Attention Deficit Hyperactivity Disorder market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 9. Global Attention Deficit Hyperactivity Disorder market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 10. Global Attention Deficit Hyperactivity Disorder market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 11. Global Attention Deficit Hyperactivity Disorder market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 12. Global Attention Deficit Hyperactivity Disorder market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 13. Global Attention Deficit Hyperactivity Disorder market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 14. Global Attention Deficit Hyperactivity Disorder market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 15. Global Attention Deficit Hyperactivity Disorder market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 16. U.S. Attention Deficit Hyperactivity Disorder market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 17. U.S. Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 18. U.S. Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 19. Canada Attention Deficit Hyperactivity Disorder market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 20. Canada Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 21. Canada Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 22. UK Attention Deficit Hyperactivity Disorder market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 23. UK Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 24. UK Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 25. Germany Attention Deficit Hyperactivity Disorder market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 26. Germany Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 27. Germany Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 28. France Attention Deficit Hyperactivity Disorder market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 29. France Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 30. France Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 31. Italy Attention Deficit Hyperactivity Disorder market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 32. Italy Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 33. Italy Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 34. Spain Attention Deficit Hyperactivity Disorder market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 35. Spain Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 36. Spain Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 37. RoE Attention Deficit Hyperactivity Disorder market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 38. RoE Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 39. RoE Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 40. China Attention Deficit Hyperactivity Disorder market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 41. China Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 42. China Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 43. India Attention Deficit Hyperactivity Disorder market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 44. India Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 45. India Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 46. Japan Attention Deficit Hyperactivity Disorder market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 47. Japan Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 48. Japan Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 49. Australia Attention Deficit Hyperactivity Disorder market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 50. Australia Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 51. Australia Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 52. South Korea Attention Deficit Hyperactivity Disorder market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 53. South Korea Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 54. South Korea Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 55.
  • TABLE 56. RoAPAC Attention Deficit Hyperactivity Disorder market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 57. RoAPAC Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 58. RoAPAC Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 59. Brazil Attention Deficit Hyperactivity Disorder market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 60. Brazil Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 61. Brazil Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 62. Mexico Attention Deficit Hyperactivity Disorder market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 63. Mexico Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 64. Mexico Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 65. RoLA Attention Deficit Hyperactivity Disorder market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 66. RoLA Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 67. RoLA Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 68. Saudi Arabia Attention Deficit Hyperactivity Disorder market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 69. Saudi Arabia Attention Deficit Hyperactivity Disorder market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 70. Saudi Arabia Attention Deficit Hyperactivity Disorder market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 71. South Africa Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 72.
  • TABLE 73. South Africa Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 74. South Africa Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 75. RoMEA Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 76. RoMEA Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 77. RoMEA Attention Deficit Hyperactivity Disorder market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 78. List of secondary sources, used in the study of Global Attention Deficit Hyperactivity Disorder Market.
  • TABLE 79. List of primary sources, used in the study of Global Attention Deficit Hyperactivity Disorder Market.
  • TABLE 80. Years considered for the study.
  • TABLE 81. Exchange rates considered

LIST OF FIGURES

  • FIG 1. Global Attention Deficit Hyperactivity Disorder market, research methodology
  • FIG 2. Global Attention Deficit Hyperactivity Disorder market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods.
  • FIG 4. Global Attention Deficit Hyperactivity Disorder market, key trends 2023
  • FIG 5. Global Attention Deficit Hyperactivity Disorder market, growth prospects 2022-2032
  • FIG 6. Global Attention Deficit Hyperactivity Disorder market, porters 5 force model
  • FIG 7. Global Attention Deficit Hyperactivity Disorder market, pestel analysis
  • FIG 8. Global Attention Deficit Hyperactivity Disorder market, value chain analysis
  • FIG 9. Global Attention Deficit Hyperactivity Disorder market by segment, 2022 & 2032 (USD Billion)
  • FIG 10. Global Attention Deficit Hyperactivity Disorder market by segment, 2022 & 2032 (USD Billion)
  • FIG 11. Global Attention Deficit Hyperactivity Disorder market by segment, 2022 & 2032 (USD Billion)
  • FIG 12. Global Attention Deficit Hyperactivity Disorder market by segment, 2022 & 2032 (USD Billion)
  • FIG 13. Global Attention Deficit Hyperactivity Disorder market by segment, 2022 & 2032 (USD Billion)
  • FIG 14. Global Attention Deficit Hyperactivity Disorder market, regional snapshot 2022 & 2032
  • FIG 15. North America Attention Deficit Hyperactivity Disorder market 2022 & 2032 (USD Billion)
  • FIG 16. Europe Attention Deficit Hyperactivity Disorder market 2022 & 2032 (USD Billion)
  • FIG 17. Asia pacific Attention Deficit Hyperactivity Disorder market 2022 & 2032 (USD Billion)
  • FIG 18. Latin America Attention Deficit Hyperactivity Disorder market 2022 & 2032 (USD Billion)
  • FIG 19. Middle East & Africa Attention Deficit Hyperactivity Disorder market 2022 & 2032 (USD Billion)
  • FIG 20. Global Attention Deficit Hyperactivity Disorder market, company market share analysis (2023)
目次

Global Attention Deficit Hyperactivity Disorder Market is valued approximately USD 14.3 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 3.70% over the forecast period 2024-2032. Attention Deficit Hyperactivity Disorder is a neurodevelopmental disorder that typically manifests in childhood and often continues into adulthood. It is characterized by persistent patterns of inattention, hyperactivity, and impulsivity that interfere with functioning or development. Also, new and improved medications are continually being developed. There is a shift towards long-acting stimulants and non-stimulant medications, offering more options for patients who may not respond well to traditional treatments. Non-stimulant medications, such as guanfacine and atomoxetine, are gaining popularity due to their lower risk of abuse and better side effect profiles for some patients. Thus, this trend is anticipated to support the growth of Global Attention Deficit Hyperactivity Disorder Market

Moreover, the awareness and recognition of ADHD have increased globally, leading to higher diagnosis rates. Improved diagnostic criteria and better screening processes have contributed to more individuals being identified and treated for ADHD. Also, there have been significant advancements in both pharmacological and non-pharmacological treatments for ADHD. New medications with improved efficacy and safety profiles, as well as behavioral therapies and digital therapeutics, are expanding the market. Additionally, growing public and professional awareness about ADHD, its symptoms, and its impact on quality of life is encouraging more people to seek diagnosis and treatment. Educational campaigns and advocacy by healthcare organizations and patient groups are instrumental in this regard, which anticipated to support the market growth. However, the stringent administration and governing procedures, an upsurge in medication prices, and the limited availability of non-stimulants ADHD drugs are the factors most expected to hinder the growth of the Global Attention Deficit Hyperactivity Disorder Market during the forecast period 2024-2032.

The key regions considered for the Global Attention Deficit Hyperactivity Disorder Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America was the largest regional market in terms of revenue. The attention deficit hyperactivity disorder market in North America is expanding owing to the introduction and rapid adoption of various medications. Furthermore, favourable reimbursement policies, increasing awareness of current treatment methods, improved patient affordability, and the introduction of new products are all expected to propel market expansion throughout the projection period. In September 2023, Tris Pharma, Inc. announced that Health Canada had approved the use of Quillivant ER (extended-release) to treat ADHD in children aged six to twelve years. Quillivant ER will be available in oral suspension and chewable tablet forms, marking the first time in Canada that once-daily, long-acting methylphenidate chewable and oral suspension formulations have been approved for ADHD treatment. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period.

Major market player included in this report are:

  • Eli Lilly and Company
  • Pfizer Inc.
  • Johnson & Johnson Services Inc.
  • Lupin Limited
  • Novartis AG
  • Takeda Pharmaceutical Company Limited
  • Mallinckrodt Inc.
  • Purdue Pharma LP
  • NEOS Therapeutics Inc.
  • Supernus Pharmaceutical, Inc.

The detailed segments and sub-segment of the market are explained below:

By Drug Type

  • Stimulants
  • Non-stimulants

By Demographics

  • Children
  • Adults

By Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market

Table of Contents

Chapter 1. Global Attention Deficit Hyperactivity Disorder Market Definition and Research Assumptions

  • 1.1. Research Objective
  • 1.2. Market Definition
  • 1.3. Research Assumptions
    • 1.3.1. Inclusion & Exclusion
    • 1.3.2. Limitations
    • 1.3.3. Supply Side Analysis
      • 1.3.3.1. Availability
      • 1.3.3.2. Infrastructure
      • 1.3.3.3. Regulatory Environment
      • 1.3.3.4. Market Competition
      • 1.3.3.5. Economic Viability (Consumer's Perspective)
    • 1.3.4. Demand Side Analysis
      • 1.3.4.1. Regulatory frameworks
      • 1.3.4.2. Technological Advancements
      • 1.3.4.3. Environmental Considerations
      • 1.3.4.4. Consumer Awareness & Acceptance
  • 1.4. Estimation Methodology
  • 1.5. Years Considered for the Study
  • 1.6. Currency Conversion Rates

Chapter 2. Executive Summary

  • 2.1. Global Attention Deficit Hyperactivity Disorder Market Size & Forecast (2022- 2032)
  • 2.2. Regional Summary
  • 2.3. Segmental Summary
    • 2.3.1. By Drug Type
    • 2.3.2. By Demographics
    • 2.3.3. By Distribution Channel
  • 2.4. Key Trends
  • 2.5. Recession Impact
  • 2.6. Analyst Recommendation & Conclusion

Chapter 3. Global Attention Deficit Hyperactivity Disorder Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Challenges
  • 3.3. Market Opportunities

Chapter 4. Global Attention Deficit Hyperactivity Disorder Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Attention Deficit Hyperactivity Disorder Market Size & Forecasts by Drug Type 2022-2032

  • 5.1. Stimulants
  • 5.2. Non-stimulants

Chapter 6. Global Attention Deficit Hyperactivity Disorder Market Size & Forecasts by Demographics 2022-2032

  • 6.1. Children
  • 6.2. Adults

Chapter 7. Global Attention Deficit Hyperactivity Disorder Market Size & Forecasts by Distribution Channel 2022-2032

  • 7.1. Retail Pharmacy
  • 7.2. Hospital Pharmacy

Chapter 8. Global Attention Deficit Hyperactivity Disorder Market Size & Forecasts by Region 2022-2032

  • 8.1. North America Attention Deficit Hyperactivity Disorder Market
    • 8.1.1. U.S. Attention Deficit Hyperactivity Disorder Market
      • 8.1.1.1. Drug Type breakdown size & forecasts, 2022-2032
      • 8.1.1.2. Demographics breakdown size & forecasts, 2022-2032
      • 8.1.1.3. Distribution Channel breakdown size & forecasts, 2022-2032
    • 8.1.2. Canada Attention Deficit Hyperactivity Disorder Market
  • 8.2. Europe Attention Deficit Hyperactivity Disorder Market
    • 8.2.1. U.K. Attention Deficit Hyperactivity Disorder Market
    • 8.2.2. Germany Attention Deficit Hyperactivity Disorder Market
    • 8.2.3. France Attention Deficit Hyperactivity Disorder Market
    • 8.2.4. Spain Attention Deficit Hyperactivity Disorder Market
    • 8.2.5. Italy Attention Deficit Hyperactivity Disorder Market
    • 8.2.6. Rest of Europe Attention Deficit Hyperactivity Disorder Market
  • 8.3. Asia-Pacific Attention Deficit Hyperactivity Disorder Market
    • 8.3.1. China Attention Deficit Hyperactivity Disorder Market
    • 8.3.2. India Attention Deficit Hyperactivity Disorder Market
    • 8.3.3. Japan Attention Deficit Hyperactivity Disorder Market
    • 8.3.4. Australia Attention Deficit Hyperactivity Disorder Market
    • 8.3.5. South Korea Attention Deficit Hyperactivity Disorder Market
    • 8.3.6. Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market
  • 8.4. Latin America Attention Deficit Hyperactivity Disorder Market
    • 8.4.1. Brazil Attention Deficit Hyperactivity Disorder Market
    • 8.4.2. Mexico Attention Deficit Hyperactivity Disorder Market
    • 8.4.3. Rest of Latin America Attention Deficit Hyperactivity Disorder Market
  • 8.5. Middle East & Africa Attention Deficit Hyperactivity Disorder Market
    • 8.5.1. Saudi Arabia Attention Deficit Hyperactivity Disorder Market
    • 8.5.2. South Africa Attention Deficit Hyperactivity Disorder Market
    • 8.5.3. Rest of Middle East & Africa Attention Deficit Hyperactivity Disorder Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Eli Lilly and Company
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Market Strategies
    • 9.3.2. Pfizer Inc.
    • 9.3.3. Johnson & Johnson Services Inc.
    • 9.3.4. Lupin Limited
    • 9.3.5. Novartis AG
    • 9.3.6. Takeda Pharmaceutical Company Limited
    • 9.3.7. Mallinckrodt Inc.
    • 9.3.8. Purdue Pharma LP
    • 9.3.9. NEOS Therapeutics Inc.
    • 9.3.10. Supernus Pharmaceutical, Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes